Site specific predictors of positive margins at radical prostatectomy: An argument for risk based modification of technique

被引:22
作者
Rabbani, F [1 ]
Bastar, A [1 ]
Fair, WR [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA
关键词
prostatic neoplasms; prostatectomy; multivariate analysis;
D O I
10.1016/S0022-5347(01)62394-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We identify patients at high risk for positive bladder neck, apical or posterior margins who may benefit from technical modifications, such as excision of the bladder neck or wide excision of the neurovascular bundles. Materials and Methods: We studied 242 patients with clinically localized prostate cancer undergoing radical prostatectomy with or without neoadjuvant androgen deprivation therapy between June 1992 and August 1997 who had a sextant biopsy available for review. Multivariate logistic regression analysis was used to develop models for prediction of positive bladder neck, apical, and right and left posterior margins based on clinical parameters. From these models patients at low and high risk for positive margins were identified. Results: The incidence of positive margins was 36% with 69% solitary sites. Patients with a prostate specific antigen of greater than 10 ng./ml. had a higher incidence (16%) of positive bladder neck margins. Patients with 3 or more positive cores who did not receive neoadjuvant androgen deprivation therapy had a higher incidence (24%) of positive apical margins. A nomogram incorporating pretreatment serum prostate specific antigen, number of ipsilateral positive cores and whether androgen deprivation therapy was used identified patients at high risk for positive posterior margins. Conclusions: The nomograms presented identify patients at high risk for positive margins at various sites who may benefit from modification of surgical technique based on risk.
引用
收藏
页码:1727 / 1733
页数:7
相关论文
共 36 条
[11]  
2-Y
[12]   Incidence and significance of positive margins in radical prostatectomy specimens [J].
Epstein, JI .
UROLOGIC CLINICS OF NORTH AMERICA, 1996, 23 (04) :651-&
[13]   Prediction of progression following radical prostatectomy - A multivariate analysis of 721 men with long-term follow-up [J].
Epstein, JI ;
Partin, AW ;
Sauvageot, J ;
Walsh, PC .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (03) :286-292
[14]   Prognostic implications of a positive apical margin in radical prostatectomy specimens [J].
Fesseha, T ;
Sakr, W ;
Grignon, D ;
Banerjee, M ;
Wood, DP ;
Pontes, JE .
JOURNAL OF UROLOGY, 1997, 158 (06) :2176-2179
[15]   Radical prostatectomy with preservation of urinary continence [J].
Gaker, DL ;
Gaker, LB ;
Stewart, JF ;
Gillenwater, JY .
JOURNAL OF UROLOGY, 1996, 156 (02) :445-449
[16]  
Goldenberg S. Larry, 1997, Journal of Urology, V157, P92
[17]   Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer [J].
Goldenberg, SL ;
Klotz, LH ;
Srigley, J ;
Jewett, MAS ;
Mador, D ;
Fradet, Y ;
Barkin, J ;
Chin, J ;
Paquin, JM ;
Bullock, MJ ;
Sullivan, LD ;
Gleave, ME ;
McLoughlin, MG ;
Prestage, K ;
Kinahan, TJ ;
Orovan, WL ;
Whelan, JP ;
Herschorn, S ;
Keresteci, AG ;
Robinette, M ;
Bruce, A ;
Stewart, DA ;
Ruether, JD ;
Ernst, DS ;
Chetner, M ;
Metcalfe, JB ;
Elhilali, M ;
Aprikian, AG ;
Bertrand, PE ;
Schick, E ;
Tessier, J ;
Halsall, AK ;
Weckworth, PF .
JOURNAL OF UROLOGY, 1996, 156 (03) :873-877
[18]   BLADDER NECK PRESERVATION AND ITS IMPACT ON POSITIVE SURGICAL MARGINS DURING RADICAL PROSTATECTOMY [J].
GOMEZ, CA ;
SOLOWAY, MS ;
CIVANTOS, F ;
HACHIYA, T .
UROLOGY, 1993, 42 (06) :689-693
[19]   A COMPARISON OF THE MORPHOLOGICAL FEATURES OF CANCER ARISING IN THE TRANSITION ZONE AND IN THE PERIPHERAL ZONE OF THE PROSTATE [J].
GREENE, DR ;
WHEELER, TM ;
EGAWA, S ;
DUNN, JK ;
SCARDINO, PT .
JOURNAL OF UROLOGY, 1991, 146 (04) :1069-1076
[20]   SYSTEMATIC BIOPSIES AND DIGITAL RECTAL EXAMINATION TO IDENTIFY THE NERVE-SPARING SIDE FOR RADICAL PROSTATECTOMY WITHOUT RISK OF POSITIVE MARGIN IN PATIENTS WITH CLINICAL STAGE-T2, N0 PROSTATIC-CARCINOMA [J].
HULAND, H ;
HUBNER, D ;
HENKE, RP .
UROLOGY, 1994, 44 (02) :211-214